Covering the operations of the oil and gas industry
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Contact
About Us
Subscribe
Newsletters
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by INVENTIVA
< Previous
1
2
3
Next >
Inventiva reports 2025 Third Quarter Financial Information¹
November 21, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
November 17, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
November 13, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
November 13, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris
November 13, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces launch of public offering
November 12, 2025
From
INVENTIVA
Via
GlobeNewswire
Statement of total voting rights and shares forming the company’s share capital as October 20, 2025
November 06, 2025
From
INVENTIVA
Via
GlobeNewswire
Combined General Meeting of November 27, 2025 - Availability of the preparatory documents
November 06, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva Announces the Implementation of a New ATM Program
October 14, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
October 07, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
October 01, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update
September 29, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva to Host Analyst and Investor Event on October 8, 2025
September 24, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva to Participate in Upcoming September Investor Conferences
September 04, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference
August 11, 2025
From
INVENTIVA
Via
GlobeNewswire
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
July 31, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
July 29, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
July 09, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva receives $10 million milestone payment from CTTQ
July 07, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
July 02, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
June 10, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
May 27, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva reports 2025 First Quarter Financial Information¹
May 23, 2025
From
INVENTIVA
Via
GlobeNewswire
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025
May 23, 2025
From
INVENTIVA
Via
GlobeNewswire
Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
May 22, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
May 05, 2025
From
INVENTIVA
Via
GlobeNewswire
Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
April 30, 2025
From
INVENTIVA
Via
GlobeNewswire
Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
April 30, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor
April 24, 2025
From
INVENTIVA
Via
GlobeNewswire
Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
April 15, 2025
From
INVENTIVA
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
